Trillium Therapeutics Revenue 2013-2019 | TRIL

Trillium Therapeutics revenue from 2013 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Trillium Therapeutics Annual Revenue
(Millions of US $)
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
2012 $
Trillium Therapeutics Quarterly Revenue
(Millions of US $)
Q3 2019 $0
Q2 2019 $0
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2012
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.016B $0.000B
Trillium Therapeutics Inc. is a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer. The company's lead program, SIRPaFc (TTI-621), is a fusion protein that consists of the CD47-binding domain of human SIRPa linked to the Fc region of a human immunoglobulin (IgG1). It is designed to act as a soluble decoy receptor, preventing CD47 from delivering its inhibitory (`do not eat`) signal. Neutralization of the inhibitory CD47 signal enables the activation of macrophage anti-tumor effects by pro-phagocytic (`eat`) signals. A Phase 1 clinical trial (NCT02663518) evaluating SIRPaFc is ongoing. Trillium also has a proprietary medicinal chemistry platform, using unique fluorine chemistry, which permits the creation of new chemical entities from validated drugs and drug candidates with improved pharmacological properties.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $63.060B 9.97
Zoetis (ZTS) United States $59.275B 35.46
Astellas Pharma (ALPMY) Japan $32.280B 16.12
Eisai (ESALY) Japan $21.727B 41.90
Grifols, S.A (GRFS) Spain $15.656B 20.51
UCB SA (UCBJF) Belgium $15.483B 0.00
Merck (MKGAF) Germany $14.519B 19.81
Neurocrine Biosciences (NBIX) United States $10.185B 480.83
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Ionis Pharmaceuticals (IONS) United States $8.869B 17.96
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.366B 10.69
Catalent (CTLT) United States $7.636B 31.07
IPSEN SA ADR (IPSEY) France $7.310B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $6.361B 96.32
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.226B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.058B 18.18
FibroGen (FGEN) United States $4.074B 119.72
United Therapeutics (UTHR) United States $3.933B 0.00
Sage Therapeutics (SAGE) United States $3.776B 0.00
Nektar Therapeutics (NKTR) United States $3.742B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.577B 13.07
Evotec AG (EVTCY) Germany $3.562B 58.28
PTC Therapeutics (PTCT) United States $2.974B 0.00
ArQule (ARQL) United States $2.423B 0.00
Heron Therapeutics (HRTX) United States $2.289B 0.00
Zogenix (ZGNX) United States $2.163B 0.00
Xencor (XNCR) United States $2.119B 64.41
Portola Pharmaceuticals (PTLA) United States $2.047B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.006B 63.95
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.979B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.906B 56.40
Tilray (TLRY) Canada $1.869B 0.00
ChemoCentryx (CCXI) United States $1.823B 0.00
USANA Health Sciences (USNA) United States $1.640B 17.50
Corcept Therapeutics (CORT) United States $1.472B 17.89
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.424B 9.71
Enanta Pharmaceuticals (ENTA) United States $1.314B 30.00
CLINIGEN GP (CLIGF) United Kingdom $1.245B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.240B 0.00
Karyopharm Therapeutics (KPTI) United States $1.052B 0.00
Endo (ENDP) Ireland $1.050B 1.93
Aerie Pharmaceuticals (AERI) United States $1.042B 0.00
Radius Health (RDUS) United States $1.033B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.944B 0.00
Akebia Therapeutics (AKBA) United States $0.760B 0.00
Flexion Therapeutics (FLXN) United States $0.756B 0.00
Collegium Pharmaceutical (COLL) United States $0.702B 0.00
Dermira (DERM) United States $0.692B 0.00
TherapeuticsMD (TXMD) United States $0.624B 0.00
ImmunoGen (IMGN) United States $0.536B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.529B 0.00
Translate Bio (TBIO) United States $0.519B 0.00
Organogenesis Holdings (ORGO) United States $0.464B 0.00
Ardelyx (ARDX) United States $0.461B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.457B 55.38
Aptorum Group (APM) Hong Kong, SAR China $0.441B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.441B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.438B 18.88
Harpoon Therapeutics (HARP) United States $0.419B 0.00
Molecular Templates (MTEM) United States $0.395B 0.00
Indivior (INVVY) United States $0.392B 1.42
OptiNose (OPTN) United States $0.388B 0.00
Recro Pharma (REPH) United States $0.382B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.374B 0.00
DURECT (DRRX) United States $0.373B 0.00
Siga Technologies (SIGA) United States $0.364B 8.31
Lannett Co Inc (LCI) United States $0.363B 4.23
Innate Pharma SA (IPHYF) France $0.336B 0.00
Rafael Holdings (RFL) United States $0.327B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.326B 0.00
Jounce Therapeutics (JNCE) United States $0.306B 4.09
KalVista Pharmaceuticals (KALV) United States $0.302B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.270B 0.00
GlycoMimetics (GLYC) United States $0.258B 0.00
Calithera Biosciences (CALA) United States $0.244B 0.00
Concordia (CXRXF) Canada $0.230B 0.00
Xeris Pharmaceuticals (XERS) United States $0.224B 0.00
Concert Pharmaceuticals (CNCE) United States $0.215B 0.00
Ocular Therapeutix (OCUL) United States $0.195B 0.00
Nature's Sunshine Products (NATR) United States $0.183B 31.53
AcelRx Pharmaceuticals (ACRX) United States $0.180B 0.00
Taiwan Liposome (TLC) Taiwan $0.175B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.171B 0.00
IMV INC (IMV) Canada $0.149B 0.00
MEI Pharma (MEIP) United States $0.149B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.137B 0.00
Aquestive Therapeutics (AQST) United States $0.132B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.127B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
CV Sciences (CVSI) United States $0.118B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.092B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.091B 0.00
CTI BioPharma (CTIC) United States $0.087B 0.00
MediWound (MDWD) Israel $0.084B 0.00
Capnia (SLNO) United States $0.084B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.080B 24.09
Champions Oncology (CSBR) United States $0.079B 0.00
Aclaris Therapeutics (ACRS) United States $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Neos Therapeutics (NEOS) United States $0.074B 0.00
PolarityTE (PTE) United States $0.070B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.070B 0.00
Nivalis Therapeutics (ALPN) United States $0.068B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
Pharmaxis (PXSLY) Australia $0.065B 0.00
RENEURON GP (RNUGF) United Kingdom $0.062B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 0.00
Natural Alternatives (NAII) United States $0.059B 14.73
Novan (NOVN) United States $0.059B 0.00
Genocea Biosciences (GNCA) United States $0.057B 0.00
Mast Therapeutics (SVRA) United States $0.056B 0.00
Forward Pharma (FWP) Denmark $0.054B 0.00
Medicure (MCUJF) Canada $0.053B 0.00
IntelGenx Technologies (IGXT) Canada $0.051B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.049B 0.00
ElectroCore (ECOR) United States $0.046B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.045B 0.00
SCYNEXIS (SCYX) United States $0.043B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Opexa Therapeutics (ACER) United States $0.037B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.031B 0.00
Jaguar Animal Health (JAGX) United States $0.029B 0.00
Shineco (TYHT) China $0.027B 0.00
PharmAthene (ALT) United States $0.026B 0.00
Biomerica (BMRA) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
ProPhase Labs (PRPH) United States $0.023B 0.00
China SXT Pharmaceuticals (SXTC) China $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.022B 0.00
Melinta Therapeutics (MLNT) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
VAXART, INC (VXRT) United States $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Vical (BBI) United States $0.013B 0.00
Lipocine (LPCN) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Achieve Life Sciences (ACHV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00